Artificial Intelligence in Cancer Care and Clinical Trials
Arturo Loaiza-Bonilla, MD, discusses artificial intelligence in cancer care and clinical trials.
Arturo Loaiza-Bonilla, MD, discusses artificial intelligence in cancer care and clinical trials.
Do you feel sleepy during the day? Doze off and let’s hope it’s not while you are driving? Does your bed partner wake up when…
The FDA has granted 510(k) clearance for the Ventana Kappa and Lambda Dual ISH mRNA Probe Cocktail, an assay designed to assist pathologists in diagnosing…
Since the Industrial Revolution, normal body temperature in both men and women has decreased monotonically by 0.03°C per birth decade.
Treatment with avapritinib was associated with dynamic changes in bone density based on lumbar T-scores among patients with systemic mastocytosis.
The ACR-368 OncoSignature assay has received breakthrough device designation from the FDA for use in endometrial cancer.
Nature – Applying natural language processing to health records generates a data set that can be used to predict cancer outcomes.
Nature – PELO–HBS1L and SKI complexes in the human mRNA quality control pathway exhibit a synthetic lethal interaction and may represent novel targets for the…
npj Precision Oncology – BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapy
Breelyn Wilky, MD, discusses the importance of disease screening and early diagnosis in the treatment of patients with sarcoma.
Major (Dr.) Riordan Ledgerwood has dedicated their life to healing others. Riordan’s groundbreaking career spans nearly a decade of service, from excelling as a resident…